細胞凍結培地市場：タイプ、用途、最終用途別-2025-2030年の世界予測

細胞凍結培地市場は、2023年に1億8,571万米ドルと評価され、2024年には2億166万米ドルに達すると予測され、CAGR 8.71%で成長し、2030年には3億3,325万米ドルになると予測されています。

凍結保存に使用される特殊なソリューションである細胞凍結培地は、凍結・融解プロセス中の損傷から細胞を保護することで、細胞の生存能力と機能性を維持する上で重要な役割を果たしています。細胞凍結培地の必要性は、バイオバンク、再生医療、製薬、学術研究など様々な分野での応用に起因しています。そのエンドユースの範囲は広大で、デリケートな細胞株、幹細胞、その他の生物学的材料の保存に重点を置く医療施設、研究所、バイオテクノロジー企業を包含しています。市場成長の原動力となっているのは、生物医学研究への投資の増加、再生医療の進歩、生物製剤のニーズの高まりであり、これらは革新的な保存方法への需要を煽っています。バイオテクノロジーの研究開発インフラが拡充されつつある新興国市場や、持続可能性を促進しながら汚染やアレルギー反応のリスクを最小限に抑える環境に優しい無血清製剤の開発には機会が豊富にあります。主な成長要因としては、技術の進歩、個別化医療への注目の高まり、幹細胞治療への需要の高まりなどが挙げられ、これらは効果的な凍結保存戦略の採用を促進しています。同市場における課題としては、高度な凍結培地の高コストや、解凍後の細胞生存率の維持に関連する技術的課題などが挙げられます。さらに、規制上の制約や厳しい品質管理基準が市場の急速な拡大を妨げる可能性もあります。このような課題を軽減するために、企業は業界標準に適合した費用対効果が高く効率的な代替品の開発に注力すべきです。技術革新の分野には、細胞回収率を高めるための凍結保護剤の処方強化、自動凍結保存システムの統合、より幅広い種類の細胞の保存を向上させる新規添加剤の開発などが含まれます。戦略的成長のためには、イノベーションを推進するための学術・研究機関との連携や、高度な凍結保存ソリューションの利点と応用に関する認知度を高めるための市場教育への投資も検討すべきです。全体として、細胞凍結培地市場はダイナミックな機会を示しているが、その可能性を完全に実現するためには、特定の技術的・コスト的障壁を克服する必要があります。

市場力学：急速に進化する細胞凍結培地市場の主要市場インサイトを公開

細胞凍結培地市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 先端バイオ医薬品に対する需要の急増とそれに伴うバイオバンキング活動の成長
  • 細胞培養ベースのワクチンへの投資の増加
  • バイオ医薬品製造におけるシングルユース技術への嗜好の高まり
• 市場抑制要因
  • 細胞生物学研究に伴う高コスト
• 市場機会
  • 再生医療の進展と高品質の凍結保存技術の必要性
  • 培地凍結保存におけるAIやIoTなどの先端技術の統合
• 市場の課題
  • 細胞凍結培地の承認と使用に関する厳しい規制要件

ポーターのファイブフォース：細胞凍結培地市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、細胞凍結培地市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：細胞凍結培地市場における外部からの影響の把握

外部マクロ環境要因は、細胞凍結培地市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析細胞凍結培地市場における競合情勢の把握

細胞凍結培地市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス細胞凍結培地市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、細胞凍結培地市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨細胞凍結培地市場における成功への道筋を描く

細胞凍結培地市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 先進的なバイオ医薬品に対する需要の高まりとそれに伴うバイオバンキング活動の成長
    • 細胞培養ワクチンへの投資増加
    • バイオ医薬品製造における使い捨て技術の好感度の高まり
  • 抑制要因
    • 細胞生物学調査に伴う高コスト
  • 機会
    • 再生医療の進歩と高品質の凍結保存技術の必要性
    • 培地凍結保存におけるAIやIoTなどの先端技術の統合
  • 課題
    • 細胞凍結培地の承認と使用に関する厳格な規制要件
• 市場セグメンテーション分析
  • タイプ：複雑な皮膚疾患に対応するバイオ医薬品製剤におけるグリセロールベースの媒体の利用
  • 最終用途：製薬企業やバイオテクノロジー企業における新薬の発見と開発のための細胞凍結培地の使用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 細胞凍結培地市場：タイプ別

• ジメチルスルホキシドベースの培地
• グリセロールベースの培地
• 無血清培地

第7章 細胞凍結培地市場：用途別

• バイオバンキング
• がん調査
• 遺伝子工学とCRISPR技術
• 医薬品研究開発
• 再生医療
• ワクチン開発

第8章 細胞凍結培地市場：最終用途別

• 製薬・バイオテクノロジー企業
• 調査機関

第9章 南北アメリカの細胞凍結培地市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の細胞凍結培地市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの細胞凍結培地市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • サルトリウス、ポリプラスの買収を完了
  • QkineとSartoriusの提携により、高度な細胞モデルの分析のための完全なワークフローソリューションが実現
  • ExCell Bio、ウルグアイに新工場を開設
• 戦略分析と提言

企業一覧

• Abcam Limited
• AMSBIO, Inc.
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• BPS Bioscience, Inc.
• Capricorn Scientific
• Carl Roth GmbH+Co. KG
• Celprogen Corporation
• Charles River Laboratories
• Elabscience Bionovation Inc.
• ExCell Biotechnology Co., Ltd
• Funakoshi Co., Ltd.
• HiMedia Laboratories
• Merck KGaA
• NIPPON Genetics EUROPE GmbH
• PAN-Biotech GmbH
• PromoCell GmbH
• Qiagen NV
• Sartorius AG
• STEMCELL Technologies
• Thermo Fisher Scientific Inc.
• WELGENE Inc.

LIST OF FIGURES

• FIGURE 1. CELL FREEZING MEDIA MARKET RESEARCH PROCESS
• FIGURE 2. CELL FREEZING MEDIA MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CELL FREEZING MEDIA MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CELL FREEZING MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CELL FREEZING MEDIA MARKET DYNAMICS
• TABLE 7. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY DIMETHYL SULFOXIDE-BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GLYCEROL-BASED MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY BIOBANKING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY CANCER RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY GENETIC ENGINEERING & CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL RESEARCH & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CELL FREEZING MEDIA MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES CELL FREEZING MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. CHINA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA CELL FREEZING MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ITALY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. POLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. QATAR CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM CELL FREEZING MEDIA MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 148. CELL FREEZING MEDIA MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. CELL FREEZING MEDIA MARKET, FPNV POSITIONING MATRIX, 2023

The Cell Freezing Media Market was valued at USD 185.71 million in 2023, expected to reach USD 201.66 million in 2024, and is projected to grow at a CAGR of 8.71%, to USD 333.25 million by 2030.

Cell freezing media, a specialized solution used in cryopreservation, plays a critical role in preserving the viability and functionality of cells by protecting them from damage during the freezing and thawing processes. The necessity for cell freezing media stems from its application across various fields including biobanking, regenerative medicine, pharmaceuticals, and academic research. Its end-use scope is vast, encompassing medical facilities, research laboratories, and biotech firms focusing on storing delicate cell lines, stem cells, and other biological materials. Market growth is driven by increased investments in biomedical research, advancements in regenerative medicine, and the growing need for biologics, which are fueling demand for innovative preservation methods. Opportunities are abundant in emerging markets where biotechnology R&D infrastructure is being expanded, as well as in developing eco-friendly and serum-free formulations that minimize risk of contamination and allergic reactions while promoting sustainability. Key growth influencers include technological advancements, a rising focus on personalized medicine, and increasing demand for stem cell therapies, which promote the adoption of effective cryopreservation strategies. Limitations in the market include the high cost of advanced freezing media and the technical challenges associated with maintaining cell viability post-thawing. Moreover, regulatory constraints and stringent quality control standards may hinder rapid market expansion. To mitigate such challenges, companies should focus on developing cost-effective and efficient alternatives that conform to industry standards. Areas of innovation include enhancing cryoprotectant formulations for better cell recovery rates, integrating automated cryopreservation systems, and developing novel additives that improve preservation of a wider range of cell types. For strategic growth, businesses should also consider collaborations with academic and research institutions to drive innovation, as well as investing in market education to boost awareness about the benefits and applications of advanced cryopreservation solutions. Overall, the cell freezing media market exhibits dynamic opportunities, yet requires overcoming certain technical and cost barriers to fully realize its potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Freezing Media Market

The Cell Freezing Media Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
  • Increasing investment in cell culture-based vaccines
  • Growing preference for single-use technologies in biopharmaceutical production
• Market Restraints
  • High cost associated with cell biology research
• Market Opportunities
  • Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
  • Integration of advanced technologies such as AI and IoT in media cryopreservation
• Market Challenges
  • Strict regulatory requirements for the approval and use of cell freezing media

Porter's Five Forces: A Strategic Tool for Navigating the Cell Freezing Media Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Freezing Media Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Freezing Media Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Freezing Media Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Freezing Media Market

A detailed market share analysis in the Cell Freezing Media Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Freezing Media Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Freezing Media Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Freezing Media Market

A strategic analysis of the Cell Freezing Media Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Freezing Media Market, highlighting leading vendors and their innovative profiles. These include Abcam Limited, AMSBIO, Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, BPS Bioscience, Inc., Capricorn Scientific, Carl Roth GmbH + Co. KG, Celprogen Corporation, Charles River Laboratories, Elabscience Bionovation Inc., ExCell Biotechnology Co., Ltd, Funakoshi Co., Ltd., HiMedia Laboratories, Merck KGaA, NIPPON Genetics EUROPE GmbH, PAN-Biotech GmbH, PromoCell GmbH, Qiagen NV, Sartorius AG, STEMCELL Technologies, Thermo Fisher Scientific Inc., and WELGENE Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Freezing Media Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Dimethyl Sulfoxide-based Media, Glycerol-Based Media, and Serum-Free Media.
• Based on Application, market is studied across Biobanking, Cancer Research, Genetic Engineering & CRISPR Technology, Pharmaceutical Research & Development, Regenerative Medicine, and Vaccine Development.
• Based on End-Use, market is studied across Pharmaceutical & Biotechnology Companies and Research Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. The surging demand for advanced biopharmaceuticals and the consequent growth in biobanking activities
    • 5.1.1.2. Increasing investment in cell culture-based vaccines
    • 5.1.1.3. Growing preference for single-use technologies in biopharmaceutical production
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with cell biology research
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in regenerative medicine and the need for high-quality cryopreservation techniques
    • 5.1.3.2. Integration of advanced technologies such as AI and IoT in media cryopreservation
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulatory requirements for the approval and use of cell freezing media
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Utilization of Glycerol-based media in biopharmaceutical formulations to cater to sophisticated skin conditions
  • 5.2.2. End-Use: Increasing usage of cell freezing media in pharmaceuticals and biotechnology firms for novel drug discovery and development
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cell Freezing Media Market, by Type

• 6.1. Introduction
• 6.2. Dimethyl Sulfoxide-based Media
• 6.3. Glycerol-Based Media
• 6.4. Serum-Free Media

7. Cell Freezing Media Market, by Application

• 7.1. Introduction
• 7.2. Biobanking
• 7.3. Cancer Research
• 7.4. Genetic Engineering & CRISPR Technology
• 7.5. Pharmaceutical Research & Development
• 7.6. Regenerative Medicine
• 7.7. Vaccine Development

8. Cell Freezing Media Market, by End-Use

• 8.1. Introduction
• 8.2. Pharmaceutical & Biotechnology Companies
• 8.3. Research Institutes

9. Americas Cell Freezing Media Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cell Freezing Media Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cell Freezing Media Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Sartorius completes acquisition of Polyplus
  • 12.3.2. Qkine and Sartorius Partnership Delivers a Complete Workflow Solution for the Analysis of Advanced Cell Models
  • 12.3.3. ExCell Bio Launches a New Factory in Uruguay
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abcam Limited
• 2. AMSBIO, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Bio-Techne Corporation
• 5. BPS Bioscience, Inc.
• 6. Capricorn Scientific
• 7. Carl Roth GmbH + Co. KG
• 8. Celprogen Corporation
• 9. Charles River Laboratories
• 10. Elabscience Bionovation Inc.
• 11. ExCell Biotechnology Co., Ltd
• 12. Funakoshi Co., Ltd.
• 13. HiMedia Laboratories
• 14. Merck KGaA
• 15. NIPPON Genetics EUROPE GmbH
• 16. PAN-Biotech GmbH
• 17. PromoCell GmbH
• 18. Qiagen NV
• 19. Sartorius AG
• 20. STEMCELL Technologies
• 21. Thermo Fisher Scientific Inc.
• 22. WELGENE Inc.